This entry covers evaluation under DC 6061. A clinician establishes the diagnosis separately.
How is it connected to service?
The applicable direct, secondary, aggravation or presumptive route determines the service-connection evidence. Use the evidence guide to distinguish these routes.
Explore service-connection evidence →What do the rating levels describe?
A diagnosis does not automatically establish a percentage. These are the source requirements for evaluating severity; related notes and exceptions still apply.
Compare these levels with the original rating table
Find DC 6061 in the rating schedule
The highlighted row marks this code. Nearby rows provide context and can describe other conditions. Use the full schedule for applicable headings, footnotes and exceptions.
| Rating | |
|---|---|
| 6046 Post-chiasmal disorders | |
| Impairment of Central Visual Acuity | |
| 6061 Anatomical loss of both eyes ¹ | 100 |
| 6062 No more than light perception in both eyes ¹ | 100 |
| 6063 Anatomical loss of one eye: ¹ | |
| In the other eye 5/200 (1.5/60) | 100 |
| In the other eye 10/200 (3/60) | 90 |
| In the other eye 15/200 (4.5/60) | 80 |
| In the other eye 20/200 (6/60) | 70 |
What an examination for visual impairment measures
When this code calls for evaluation of visual impairment, distinguish visual acuity, field loss and eye-muscle function in the examination report. The applicable findings depend on the condition.
Read 38 CFR §4.75 ↗Related notes and evaluation rules
Note (3): For the purposes of evaluating visual impairment due to the particular condition, refer to 38 CFR 4.75-4.78 and to § 4.79, diagnostic codes 6061-6091
Note (1): For the purposes of evaluation under 38 CFR 4.79, an incapacitating episode is an eye condition severe enough to require a clinic visit to a provider specifically for treatment purposes
Note (2): Examples of treatment may include but are not limited to: Systemic immunosuppressants or biologic agents; intravitreal or periocular injections; laser treatments; or other surgical interventions
Evaluate on the basis of either visual impairment due to the particular condition or on incapacitating episodes, whichever results in a higher evaluation |
Which evidence addresses the questions?
- The documented diagnosis and applicable diagnostic code.
- Clinical findings and functional effects addressing the applicable source criteria.
- Timing, treatment and connection-to-service evidence for the applicable claim route.
Sources and scope
Guide source check: 2026-11-06. Rating-library snapshot: June 30, 2026. Source coverage is distinct from clinical review. This page does not diagnose, adjudicate a claim, or collect medical records.
Shared reference edition 1.2.4 · source check 2026-11-06. Coverage is stated for each framework and is distinct from clinical review. Rating-source snapshot: 2026-06-30.